DNA & Genetics Ultragenyx, Mereo Plummet on Brittle Bone Candidate FailuresBy adminJanuary 5, 20260 Ultragenyx Pharmaceutical (NASDAQ: RARE) and Mereo BioPharma Group (NASDAQ: MREO) may be wishing for a happy new year in 2026…
